Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation
International Journal of Dermatology · 2024-06 · 63 (6) · 806-815
DOI: 10.1111/ijd.17189 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift International Journal of Dermatology, online erschienen am 29.04.2024. Verfasst von Andrew Alexis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Weill Cornell Medical College, New York, NY, USA. Hauptthemen laut MEDLINE: Acne Vulgaris, Hyperpigmentation, Severity of Illness Index, Skin Care. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Galderma.
Abstract (Originalsprache)
Background
Acne‐induced hyperpigmentation (AIH) may accompany acne vulgaris (AV) inflammation in all skin phototypes. Trifarotene has shown depigmenting properties in vivo. This study evaluated trifarotene plus skincare because it is increasingly recognized that holistic AV management should include skincare and treatments.
Methods
This is a phase IV double‐blind, parallel‐group study of patients (13–35 years) with moderate AV and AIH treated with trifarotene ( N = 60) or vehicle ( N = 63) plus skincare regimen (moisturizer, cleanser, and sunscreen) for 24 weeks. Assessments included the AIH overall disease severity (ODS) score, post‐AV hyperpigmentation index (PAHPI), exit interviews, photography, and acne assessments. Standard safety assessments were included.
Results
Trifarotene 50 μg/g cream improved significantly from baseline in ODS score versus vehicle (−1.6 vs. −1.1, P = 0.03) at Week 12, but scores were comparable between groups at Week 24 (primary endpoint). Trifarotene had a better reduction in PAHPI score at Week 24 (−18.9% vs. −11.3% vehicle, P < 0.01). Lesion count reductions were higher with trifarotene at Week 12 versus vehicle ( P < 0.001) and at Week 24 ( P < 0.05), as were IGA success rates versus vehicle at Weeks 12 ( P < 0.05) and 24 ( P < 0.05). Patients agreed that the skincare regimen contributed to less irritation, making treatment adherence easier. Photography showed improvements in pigmentation and erythema across all skin types. AEs were more common in the vehicle group versus trifarotene (30.2 vs. 16.7%, respectively).
Conclusions
In all skin phototypes, there was more rapid improvement in the ODS and PAHPI scores with trifarotene by Weeks 12 and 24, respectively. The combination of trifarotene and skincare correlated with high patient satisfaction and adherence to the treatment protocol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Weill Cornell Medical College, New York, NY, USA.
- JDR Dermatology Research, Las Vegas, NV, USA.
- ForCare Medical Center, Tampa, FL, USA.
- Hospital de Manises, Valencia, Spain.
- Baylor College of Medicine, Houston, TX, USA.
- First OC Dermatology Research Inc., Fountain Valley, CA, USA.
ORCID-Profile: Rajeev Chavda
Förderung
- Galderma
Zitieren
APA
Alexis, A., Del Rosso, J. Q., Forman, S., Martorell, A., Browning, J., Laquer, V., Desai, S. R., York, J. P., Chavda, R., Dhawan, S., Moore, A. Y., & Stein-Gold, L. (2024). Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation. International Journal of Dermatology, 63(6), 806-815. https://doi.org/10.1111/ijd.17189
Vancouver
Alexis A, Del Rosso JQ, Forman S, Martorell A, Browning J, Laquer V, et al. Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation. International Journal of Dermatology. 2024;63(6):806-815. doi:10.1111/ijd.17189
BibTeX
@article{Alexis2024,
author = {Alexis, Andrew and Del Rosso, James Q and Forman, Seth and Martorell, Antonio and Browning, John and Laquer, Vivian and Desai, Seemal R and York, Jean Philippe and Chavda, Rajeev and Dhawan, Sunil and Moore, Angela Y and Stein-Gold, Linda},
title = {Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation},
journal = {International Journal of Dermatology},
year = {2024},
volume = {63},
number = {6},
pages = {806--815},
doi = {10.1111/ijd.17189}
}
EUVIMED